Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04724252 · ClinicalTrials.gov registry record · Phase 2

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

A Phase 2 study of Pain, Postoperative, sponsored by University of California, Davis.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT04724252 is a Phase 2 study of Pain, Postoperative that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 60 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04724252, a Phase 2 study of Pain, Postoperative, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Gabapentin

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-08-23
Est. Completion 2026-12-31
Phase Phase 2

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04724252

The ClinicalTrials.gov registry entry for NCT04724252 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (78% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04724252 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04724252 about?

NCT04724252 is a clinical study titled "Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children". The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not ...

What is the current status of trial NCT04724252?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-08-23. Estimated completion is 2026-12-31.

What conditions does trial NCT04724252 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT04724252?

The interventions under investigation include: Placebo (OTHER), Gabapentin (DRUG).

Who is sponsoring clinical trial NCT04724252?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04724252 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.